Carl Zeiss Meditec AG
General ticker "CZMWF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $5.1B (TTM average)
Carl Zeiss Meditec AG does not follow the US Stock Market performance with the rate: -38.1%.
Estimated limits based on current volatility of 2.6%: low 33.78$, high 35.98$
Factors to consider:
- Earnings expected soon, date: 2026-02-12 bmo
- Company pays dividends (annually): last record date 2025-03-28, amount 0.65$ (Y1.89%)
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [39.09$, 83.21$]
- 2025-09-30 to 2026-09-30 estimated range: [37.82$, 78.95$]
Financial Metrics affecting the CZMWF estimates:
- Negative: with PPE of 30.1 at the end of fiscal year the price was high
- Positive: -5.04 < Operating profit margin, % of 5.87
- Positive: 42.77 < Shareholder equity ratio, % of 60.17 <= 64.37
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 5.04
- Positive: -9.11 < Industry operating profit margin (median), % of -7.75
- Positive: -14.20 < Investing cash flow per share per price, % of -7.91
- Negative: negative Industry operating cash flow (median)
- Negative: 0 < Inventory ratio change, % of 0.69
- Positive: Interest expense per share per price, % of 0.56 <= 0.73
Short-term CZMWF quotes
Long-term CZMWF plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 |
|---|---|---|
| Operating Revenue | €2,089.30MM | €2,066.13MM |
| Operating Expenses | €1,762.16MM | €1,944.78MM |
| Operating Income | €327.14MM | €121.35MM |
| Non-Operating Income | €85.43MM | €119.52MM |
| Interest Expense | €1.92MM | €29.42MM |
| R&D Expense | €349.28MM | €343.09MM |
| Income(Loss) | €412.56MM | €240.87MM |
| Taxes | €120.56MM | €60.71MM |
| Profit(Loss)* | €290.40MM | €178.73MM |
| Stockholders Equity | €2,159.45MM | €2,041.70MM |
| Inventory | €519.62MM | €536.16MM |
| Assets | €3,032.92MM | €3,393.20MM |
| Operating Cash Flow | €250.86MM | €247.32MM |
| Capital expenditure | €113.86MM | €152.20MM |
| Investing Cash Flow | €-110.98MM | €-412.31MM |
| Financing Cash Flow | €-135.09MM | €176.25MM |
| Earnings Per Share** | €3.25 | €2.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.